Review, 2018 : Influenza A Viral Infections Drug Development Pipeline
Press Release - 09
May2018
Global
Research and Development News
--
.
.
"Influenza
A Viral Infections Drug Development Pipeline Review, 2018"
with coming years Industries Trends, projections of Global Growth,
Major key player and Case study, Review, Share, Size, Effect.
'
'
~
Summary
~
This report provides an overview of the pipeline landscape for influenza A viral infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A H3N2, H1N1, H5N1 and H7N9 subtype infections, and features dormant and discontinued products.. .
This report provides an overview of the pipeline landscape for influenza A viral infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A H3N2, H1N1, H5N1 and H7N9 subtype infections, and features dormant and discontinued products.. .
'
'
Influenza
is an acute infection of the respiratory tract that predominately
affects the nose, throat and bronchi, and less commonly the lungs.
Influenza viruses have a single-stranded segmented RNA genome. They
belong to the family Orthomyxoviridae, and are categorized into three
genera based on their core proteins A, B and C. Influenza A and B
viruses are responsible for the majority of symptomatic cases of
influenza in humans.
Influenza A viruses can be further categorized based on their expression of two viral surface proteins: hemagglutinin (H); and neuraminidase (N). These viruses are known to have high mutation rates, with frequent changes to the viral protein structure.
~ Scope ~
- Which companies are the most active within the pipeline for influenza A viral infections?
- Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened within this field?
~ Reasons to buy ~
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Influenza A viruses can be further categorized based on their expression of two viral surface proteins: hemagglutinin (H); and neuraminidase (N). These viruses are known to have high mutation rates, with frequent changes to the viral protein structure.
~ Scope ~
- Which companies are the most active within the pipeline for influenza A viral infections?
- Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened within this field?
~ Reasons to buy ~
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
– More
Clear Details get Table of
Contents_https://www.researchmoz.us/influenza-a-viral-infections-drug-development-pipeline-review-2018-report.html/toc
'
'
1 Table of
Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 Influenza A Viral Infections Report Coverage 10
2.2 Influenza A Virus, H3N2 Subtype Infections Overview 10
2.3 Influenza A Virus, H1N1 Subtype Infections Overview 10
2.4 Influenza A Virus, H5N1 Subtype Infections Overview 10
2.5 Influenza A Virus, H7N9 Subtype Infections Overview 10
3 Therapeutics Development 11
3.1 Influenza A Virus, H3N2 Subtype Infections 11
3.2 Influenza A Virus, H1N1 Subtype Infections 19
3.3 Influenza A Virus, H5N1 Subtype Infections 31
3.4 Influenza A Virus, H7N9 Subtype Infections 41
4 Therapeutics Assessment 48
4.1 Influenza A Virus, H3N2 Subtype Infections 48
4.2 Influenza A Virus, H1N1 Subtype Infections 55
4.3 Influenza A Virus, H5N1 Subtype Infections 62
4.4 Influenza A Virus, H7N9 Subtype Infections 69
5 Companies Involved in Therapeutics Development 75
5.1 Influenza A Virus, H3N2 Subtype Infections 75
5.2 Influenza A Virus, H1N1 Subtype Infections 89
5.3 Influenza A Virus, H5N1 Subtype Infections 114
5.4 Influenza A Virus, H7N9 Subtype Infections 130
6 Dormant Projects 140
6.1 Influenza A Virus, H3N2 Subtype Infections 140
6.2 Influenza A Virus, H1N1 Subtype Infections 142
6.3 Influenza A Virus, H5N1 Subtype Infections 146
6.4 Influenza A Virus, H7N9 Subtype Infections 151
7 Discontinued Products 152
7.1 Influenza A Virus, H3N2 Subtype Infections 152
7.2 Influenza A Virus, H1N1 Subtype Infections 153
7.3 Influenza A Virus, H5N1 Subtype Infections 153
8 Product Development Milestones 154
8.1 Influenza A Virus, H3N2 Subtype Infections 154
8.2 Influenza A Virus, H1N1 Subtype Infections 160
8.3 Influenza A Virus, H5N1 Subtype Infections 174
8.4 Influenza A Virus, H7N9 Subtype Infections 185
9 Appendix 187
9.1 Methodology 187
9.2 Coverage 187
9.3 Secondary Research 187
9.4 Primary Research 187
9.5 Expert Panel Validation 187
9.6 Contact Us 188
9.7 Disclaimer 188
1.1 List of Tables
Table 1: Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections 11
Table 2: Number of Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 12
Table 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 14
Table 4: Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 15
Table 5: Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 18
Table 6: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections 19
Table 7: Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections 21
Table 8: Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections 23
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 Influenza A Viral Infections Report Coverage 10
2.2 Influenza A Virus, H3N2 Subtype Infections Overview 10
2.3 Influenza A Virus, H1N1 Subtype Infections Overview 10
2.4 Influenza A Virus, H5N1 Subtype Infections Overview 10
2.5 Influenza A Virus, H7N9 Subtype Infections Overview 10
3 Therapeutics Development 11
3.1 Influenza A Virus, H3N2 Subtype Infections 11
3.2 Influenza A Virus, H1N1 Subtype Infections 19
3.3 Influenza A Virus, H5N1 Subtype Infections 31
3.4 Influenza A Virus, H7N9 Subtype Infections 41
4 Therapeutics Assessment 48
4.1 Influenza A Virus, H3N2 Subtype Infections 48
4.2 Influenza A Virus, H1N1 Subtype Infections 55
4.3 Influenza A Virus, H5N1 Subtype Infections 62
4.4 Influenza A Virus, H7N9 Subtype Infections 69
5 Companies Involved in Therapeutics Development 75
5.1 Influenza A Virus, H3N2 Subtype Infections 75
5.2 Influenza A Virus, H1N1 Subtype Infections 89
5.3 Influenza A Virus, H5N1 Subtype Infections 114
5.4 Influenza A Virus, H7N9 Subtype Infections 130
6 Dormant Projects 140
6.1 Influenza A Virus, H3N2 Subtype Infections 140
6.2 Influenza A Virus, H1N1 Subtype Infections 142
6.3 Influenza A Virus, H5N1 Subtype Infections 146
6.4 Influenza A Virus, H7N9 Subtype Infections 151
7 Discontinued Products 152
7.1 Influenza A Virus, H3N2 Subtype Infections 152
7.2 Influenza A Virus, H1N1 Subtype Infections 153
7.3 Influenza A Virus, H5N1 Subtype Infections 153
8 Product Development Milestones 154
8.1 Influenza A Virus, H3N2 Subtype Infections 154
8.2 Influenza A Virus, H1N1 Subtype Infections 160
8.3 Influenza A Virus, H5N1 Subtype Infections 174
8.4 Influenza A Virus, H7N9 Subtype Infections 185
9 Appendix 187
9.1 Methodology 187
9.2 Coverage 187
9.3 Secondary Research 187
9.4 Primary Research 187
9.5 Expert Panel Validation 187
9.6 Contact Us 188
9.7 Disclaimer 188
1.1 List of Tables
Table 1: Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections 11
Table 2: Number of Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 12
Table 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 14
Table 4: Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 15
Table 5: Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 18
Table 6: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections 19
Table 7: Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections 21
Table 8: Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections 23
Continue.....
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment